Kevin Carroll
Priory Hospital Cheadle Royal(GB)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Prostate Cancer Diagnosis and Treatment, Statistical Methods in Clinical Trials, Renal Diseases and Glomerulopathies, Hormonal and reproductive studies
Most-Cited Works
- → Progression-Free Survival Is a Surrogate for Survival in Advanced Colorectal Cancer(2007)346 cited
- → BICALUTAMIDE MONOTHERAPY COMPARED WITH CASTRATION IN PATIENTS WITH NONMETASTATIC LOCALLY ADVANCED PROSTATE CANCER: 6.3 YEARS OF FOLLOWUP(2000)345 cited
- → Bicalutamide as Immediate Therapy Either Alone or as Adjuvant to Standard Care of Patients with Localized or Locally Advanced Prostate Cancer: First Analysis of the Early Prostate Cancer Program(2002)229 cited
- → BICALUTAMIDE 150 MG IN ADDITION TO STANDARD CARE IN PATIENTS WITH LOCALIZED OR LOCALLY ADVANCED PROSTATE CANCER: RESULTS FROM THE SECOND ANALYSIS OF THE EARLY PROSTATE CANCER PROGRAM AT MEDIAN FOLLOWUP OF 5.4 YEARS(2004)209 cited
- → Casodex (bicalutamide) 150-mg monotherapy compared with castration in patients with previously untreated nonmetastatic prostate cancer: results from two multicenter randomized trials at a median follow-up of 4 years(1998)164 cited
- → BICALUTAMIDE (150 MG) VERSUS PLACEBO AS IMMEDIATE THERAPY ALONE OR AS ADJUVANT TO THERAPY WITH CURATIVE INTENT FOR EARLY NONMETASTATIC PROSTATE CANCER: 5.3-YEAR MEDIAN FOLLOWUP FROM THE SCANDINAVIAN PROSTATE CANCER GROUP STUDY NUMBER 6(2004)99 cited
- → Prophylactic breast irradiation with a single dose of electron beam radiotherapy (10 Gy) significantly reduces the incidence of bicalutamide-induced gynecomastia(2004)98 cited
- → Individual- and trial-level surrogacy in colorectal cancer(2008)85 cited
- → A re‐assessment of the role of combined androgen blockade for advanced prostate cancer(2004)84 cited
- → Is there a role for antiandrogen monotherapy in patients with metastatic prostate cancer?(2001)39 cited